Direct costs associated to miningococcal disease and related sequelae in children ? analysis based on the braszilian public health system perspective

Página do item simplificado
dc.contributor.authorSalgado, JB
dc.contributor.authorSilva, DO
dc.contributor.authorLorenzato, F
dc.contributor.authorCintra, OA
dc.contributor.authorSaturnino, LT
dc.date.accessioned2022-09-16T13:01:48Z
dc.date.available2022-09-16T13:01:48Z
dc.date.issued2016
dc.description.abstractObjectives to estimate the direct medical costs, under the Brazilian Public Health System (SUS) perspective, associated to invasive meningococcal disease (IMD) in 0-to-1-year-old children and the related main sequelae tracked until they turned 18 years old. Methods a cost-of-illness study was conducted to estimate the SUS expenditure with treatment of IMD acute stage (diagnosis, inpatient treatment and chemoprophylaxis for contacts). During the period of 2007 to 2015, a total of 2,651 notified cases of 0-to-1-year-old children in Brazil were considered. The costs related to the sequelae treatment tracked until they turned 18 years old were calculated using the procedures packages based on the sequelae management recommended by SUS. The assumed sequelae frequency was 23.9% for the occurrence of at least one sequel, the most common being deafness (28%), epilepsy (28%), amputation (9%) and skin necrosis (9%). Brazilian public databases were used to identify the procedures and medications costs. Results the estimated SUS expenditure on acute stage treatment of IMD was USD 456 per patient (1USD = 3.63BRL, March-May 2016), reaching USD 1.1 million for cases in the period of 2007 to 2015. The expenditure related to the main sequelae treatment in the following 17 years was USD 2.1 million, 66% of this value being related to deafness, followed by 20% to amputation, 12% to epilepsy and 2% to skin necrosis. Conclusions the increase of healthcare expenditures reinforces the considerable economic impact of IMD. It is worth emphasizing that the direct costs in this study were estimated in a conservative approach, representing the minimal expenditures associated to IMD in Brazil. It is important to mention that direct medical costs represent only a part of IMD-associated costs. There is a need to conduct other studies that also estimate the indirect costs.en
dc.identifier.citationSalgado JB, Silva DO, Lorenzato F, Cintra OA, Saturnino LT. Direct costs associated to miningococcal disease and related sequelae in children ? analysis based on the braszilian public health system perspective. Value in Health. 2016;19(7):PA422. Doi: 10.1016/j.jval.2016.09.438.
dc.identifier.otherDOI:10.1016/j.jval.2016.09.438
dc.identifier.urihttps://dspace.inc.saude.gov.br/handle/123456789/292
dc.language.isoen
dc.publisherValue in Health
dc.subjectInfecções Meningocócicaspt
dc.subjectMeningococcal Infectionsen
dc.subjectCosten
dc.subjectCustospt
dc.subjectSaúde públicapt
dc.subjectPublic healthen
dc.subjectSistema Único de Saúde - SUSpt
dc.titleDirect costs associated to miningococcal disease and related sequelae in children ? analysis based on the braszilian public health system perspectiveen
dc.typePresentation
Arquivos
Original bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.alt
Nome:
PIIS1098301516318058.pdf
Tamanho:
67.56 KB
Formato:
Adobe Portable Document Format
Descrição:
Baixar
License bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.placeholder
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed to upon submission
Descrição:
Baixar
Coleções
Produção Discente